Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208669 · ClinicalTrials.gov registry record · NA
Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes
A NA study of Blood Pressure Control, sponsored by Elizabeth Pfoh.
- Recruiting
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 2
- Study locations
NCT07208669 is a NA study of Blood Pressure Control that is actively recruiting participants, run by Elizabeth Pfoh. The registered enrollment target is 4 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07208669, a NA study of Blood Pressure Control, is actively recruiting participants, sponsored by Elizabeth Pfoh.
- RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 2
- Study locations
Study Summary
The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observational evidence suggests that antihypertensive medication intensification increases harm. The proposed study tests whether a unit-based intervention (ACT-BP) can reduce antihypertensive medication intensification and provides information that is scientifically necessary for designing a cluster-randomized clinical trial that identifies the impact of intensification after experiencing an asymptomatically elevated BP on patient outcomes.
Conditions Studied
Interventions
- OTHER ACT-BP Intervention
Study Locations (2)
Ohio
- Cleveland Clinic Main Campus - Cleveland
- Cleveland Clinic Hillcrest - Mayfield Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2025-11-11 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07208669
The ClinicalTrials.gov registry entry for NCT07208669 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elizabeth Pfoh, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Pressure Control appearing as the primary indexed condition, and to 1 intervention - of which ACT-BP Intervention is the first listed.
NCT07208669 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07208669 about?
NCT07208669 is a clinical study titled "Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes". The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observa...
What is the current status of trial NCT07208669?
This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2025-11-11. Estimated completion is 2027-07-31.
What conditions does trial NCT07208669 study?
This clinical trial studies the following conditions: Blood Pressure Control.
What interventions are being tested in trial NCT07208669?
The interventions under investigation include: ACT-BP Intervention (OTHER).
Who is sponsoring clinical trial NCT07208669?
This trial is sponsored by Elizabeth Pfoh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208669 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.